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Abstract
The primary aim of this article is to review the use of animal health insurance data in the scientific
literature, especially in regard to morbidity or mortality in companion animals and horses. Methods
and results were compared among studies on similar health conditions from different nations and
years. A further objective was to critically evaluate benefits and limitations of such databases, to
suggest ways to maximize their utility and to discuss the future use of animal insurance data for
research purposes. Examples of studies on morbidity, mortality and survival estimates in dogs and
horses, as well as neoplasia in dogs, are discussed.
We conclude that insurance data can and should be used for research purposes in companion
animals and horses. Insurance data have been successfully used, e.g. to quantify certain features that
may have been hitherto assumed, but unmeasured. Validation of insurance databases is necessary
if they are to be used in research. This must include the description of the insured population and
an evaluation of the extent to which it represents the source population. Data content and
accuracy must be determined over time, including the accuracy/consistency of diagnostic
information. Readers must be cautioned as to limitations of the databases and, as always, critically
appraise findings and synthesize information with other research. Similar findings from different
study designs provide stronger evidence than a sole report. Insurance data can highlight common,
expensive and severe conditions that may not be evident from teaching hospital case loads but may
be significant burdens on the health of a population.
Introduction
Sources of information regarding animal populations
Background knowledge regarding the incidence and prev-
alence of disease in a population supports the diagnostic
process and is needed for effective animal-health related
services. Large-scale epidemiological studies are usually
required for estimation of incidence and prevalence of
diseases. Such studies can be conducted using primary or
secondary data sources.
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the intended research purpose [1]. Only few large-scale
population-based studies have been performed in com-
panion animals. For example, data on all excised and lab-
oratory-submitted tissues that could possibly be
considered as cancers within a defined geographic area
have been recorded [2-4]. In one of the studies the size of
the base population was also estimated, allowing approx-
imate determination of population-based rates of cancer
[3]. In horses, disease information has been recorded
together with information on the base-population of
horses in 28 states of the US, enabling determination of
population-based rates of broadly-defined disease prob-
lems [5,6].
Secondary data are those used for a purpose for which
they were not primarily assembled [1]. Many different
data sources can be considered secondary, such as retro-
spective evaluations of practice records from animal hos-
pitals, breeding club registries and medical insurance
data. Any registry that is used for research but where data
collection was not specifically designed for the particular
study should be considered secondary.
In descriptive observational small-animal or equine
research, use of secondary data is very common. This is
because primary data collection is expensive and time-
consuming, especially when a large number of individuals
are to be investigated. Because most practical observa-
tional study designs have limitations, determinants of dis-
ease will be most effectively mapped by comparisons
among multiple studies with different designs. Extrapola-
tion of findings to the general population, from even
large-scale epidemiological studies in production animals
or humans, must be done with caution. The use of sec-
ondary data in research is both justified and necessary.
However, where secondary sources are used the data qual-
ity must be shown to be adequate in terms of accuracy (i.e.
disease data are correct with respect to diagnosis) and
completeness (i.e. an adequate amount of the entire dis-
ease load of the population is available). Of course, pri-
mary collection does not ensure accurate data, and it is
possible for some secondary sources to be of very high
validity, depending on how similar the research utiliza-
tion is to the original purpose of the data collection.
Existing registries
Registries have been frequently used to study different dis-
eases in human epidemiology, especially within the Nor-
dic countries (e.g. Denmark, Finland, Norway and
Sweden), the UK and North-America. However, there are
few well-designed disease registries for dogs, cats or horses
that permit the calculation of incidence or prevalence of
disease, survival rates or the evaluation of risk factors. To
allow such calculations the registries need to have good
documentation of the base population as well as of the
occurring cases. The following are examples of existing
registries that can be used as sources of secondary infor-
mation regarding disease frequency and health in com-
panion animal and horse populations.
Clinical records
Clinical records, either hard copy or electronic, from vet-
erinary practices have been used extensively in compan-
ion animal research. Such medical records are likely to
contain more complete documentation of clinical infor-
mation (i.e. diagnoses) than clinical data subsequently
entered into, for example, an insurance database. A limi-
tation of hospital data is that the size and structure of the
source population are unknown; therefore population-
based estimates of incidence or prevalence are impossible.
If the data are from a referral hospital, the diseased popu-
lation might differ from the (unknown) catchment popu-
lation in numerous ways as both clients and animals have
passed through various filters, e.g. degree of diagnostic
work-up and financial considerations, prior to arriving at
the hospital. Among other possible biases, the patients
might be selected towards more or less complicated cases
depending on the kind of practice that is studied.
Few clinical databases are effectively monitored or vali-
dated. The Veterinary Medical Database Program (VMDP)
registry was created in the 1960's [7,8]. Most of the North-
American veterinary universities contribute data to this
registry [9]. The VMDP amalgamates information from
veterinary university animal hospitals but shares the limi-
tations of individual-hospital data, being case-based. This
large registry has been used to study general and specific
diseases [7,10] as well as longevity [8]. Although various
problems are inherent in these data, such as the mixture
of referral and primary institutions and inconsistencies in
data completeness or quality, this database has supported
many studies that would not have been possible other-
wise. If the disease studied is one which is likely to be
referred to teaching hospitals, the data may reflect the
occurrence of the problem within the general population
(e.g. [11,12]).
Kennel club data - breeding registries
Kennel club, cat or horse breeding registries contain infor-
mation about some portion of animals from a specific
area, and data are usually recorded early in each individ-
ual's life. Screening program information may be com-
pletely incorporated into the database [13,14] if all results
are entered. In other situations, results have been entered
in an incomplete form [15] when it was the decision of
the breeder/dog-owners whether or not to report the
results. Clinical data or disease recordings are unlikely to
be entered into such registries. Date of birth is probably
fairly accurately recorded, but ancestry may be more rare
[16]. The (proposed) completeness of date of birth record-
ings yields a large potential for longevity studies based onPage 2 of 9
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mation [17]. However, it has not, to our knowledge, been
possible to register date of death in these ancestry data-
bases with any reasonable degree of completeness or
avoiding volunteer bias. However, given estimates of the
longevity of the dogs from other sources, it is possible to
approximate the current breed distribution and size of the
population in a database with incomplete information on
dates of death.
Insurance data
Databases from animal health insurance companies have
become interesting to researchers because, unlike hospital
data, they contain information on the background popu-
lation as well as on clinical events. The insured popula-
tion is followed from enrolment to termination of
coverage. Medical insurance data have also been used in
human medicine, but to a lesser degree than, e.g. "proper"
disease registries from medical care. Animal insurance
data have been used for research purposes since the 1970's
[18,19] with increasing frequency during the last decade.
Individual companion animals and horses can have veter-
inary care and/or life-insurance, however, insurance terms
vary quite widely between companies and even more
among countries and continents. In general, veterinary
care insurance covers the costs of veterinary consultations/
treatments and life-insurance reimburses the value of the
animal in case of death.
Objectives
The primary aim of this paper is to review the use of ani-
mal health insurance data in the scientific literature, espe-
cially in regard to morbidity or mortality in companion
animals and horses. Methods and results were compared
among studies on similar health conditions from different
nations and years. The second objective was to critically
evaluate benefits of and limitations for the use of insur-
ance databases for research purposes. Finally, we aimed to
discuss the future of research using animal insurance data
and suggest steps to take to maximize their utility.
Methods
For the purposes of this review, directed searches of
PubMed and Web of Knowledge were made using appro-
priate terms, e.g. insurance and animal. An attempt has
also been made to access ancillary literature, e.g. theses as
well as refereed publications. The authors have been fol-
lowing the literature on morbidity and mortality in com-
panion animals for the past 15 years, and major studies
within the field are unlikely to have been missed in this
search-process. The relevant literature was deemed insuf-
ficient in scope and content to allow for a formal system-
atic review, therefore a general and critical description has
been produced. It should be noted that the majority of lit-
erature in this field has been produced by these authors
using the database of one large Swedish insurance com-
pany (Agria Djurförsäkring).
Results- Usage of insurance data in research
Publications based on animal insurance data
Papers based on animal insurance data in the scientific lit-
erature are shown in table 1 for dogs (n = 19) and table 2
for horses (n = 13). The focus is on refereed publications.
Therefore, although theses and proceedings (if later fol-
lowed by published articles) are reviewed, they are not
included in the tables. Taken together with some posters,
conference presentations and theses, no other publica-
tions concerning dogs, cats and equines were found where
insurance data had been used. Some German theses on
equine disease have been excluded (see [20,21]). The
tables provide a brief summary of the country, time-
period, whether data on mortality or morbidity are pre-
sented and the disease problem(s) (general or specific). As
can be seen from the two tables, most of the published
studies using animal insurance data are from the Agria
insurance company in Sweden and by the authors of this
review. The following sections contain some examples of
use of insurance data in research, with a comparison of
results from different populations where feasible.
General morbidity and mortality
In general, insurance data will be a source of information
on the disease load of the insured animals. This holds true
as long as disease events have veterinary care costs
attached to them, that animal owners claim those to the
insurance company and that these events are covered by
the insurance. Swedish insurance data have been used to
study general mortality and morbidity in dogs and horses,
both with respect to incidence and proportional measures
[22-27]. In general, only disease events for which the cost
exceeds the deductible will be recorded. Different levels
and applications of the deductible will influence compa-
rability across data sources (see further information
below). Distinguishing between death and euthanasia is
not possible in the Agria data. In this insurance program
most medical and traumatic problems were covered,
whereas, e.g. behavioral issues or non-traumatic tooth-
problems were not. The number of exclusions from cover-
age varies somewhat by breed and has been tending to
increase over time (personal communication, Lotta Gun-
narsson, Agria Insurance) but, during the period of these
studies, exclusions and limitations were relatively few.
Some insurance programs/companies have highly restric-
tive or individualized coverage, and researchers cannot be
certain that all disease events will be recorded equally for
all insured animals. For Swedish insurance companies,
clients are not "punished" with higher insurance fee or
exclusion from insurance if they use the insurance which
reduces the risk of not reporting disease problems in the
animals.Page 3 of 9
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base could be defined in two ways, either as total mortal-
ity including all registered deaths or as diagnostic
mortality, i.e. when an insurance claim (with a cause of
death/reason for euthanasia/diagnosis) was submitted.
The annual total and diagnostic mortality of dogs were 3
and 2%, respectively, and for horses both 4% [22,23,27].
These estimates varied with breed, gender and age in both
species and also with geographic location in horses
[22,23,27]. Among insured horses in France, an overall
mortality rate of 2.47% was reported and the most com-
mon cause of death was death as a consequence of foaling
(dead colts were also relatively common) followed by
colic and locomotor disease [28]. From the Swedish insur-
ance database, such foaling complications, nor dead colts,
were common reasons for death - although the condition
is covered by the complete insurance form (as well as by
other types of insurance). However, locomotor problems
Table 1: Published studies (n = 19) based on data from insured dogs or using insured dogs as a sampling frame in chronological order
Source Year Country1 Main focus/disease2
Bergsten et al. (1978) [18] 1975-1977 Sweden Morbidity and mortality; general and by cause
Häggström et al. (1992) [55] 1980-1990 Sweden Mortality and morbidity; myxomatous valve disease
Bonnett et al. (1997) [22] 1992, 1993 Sweden Mortality; general and by cause
Egenvall et al. (2000) [23] 1995, 1996 Sweden Morbidity and mortality; general
Egenvall et al. (2000) [24] 1996 Sweden Morbidity; general, by cause
Egenvall et al. (2000c) [36] 1995, 1996 Sweden Mortality; general
Egenvall et al. (2001) [56] 1995, 1996 Sweden Morbidity; pyometra
Dobson et al. (2002) [31] 1997-1998 UK Morbidity; neoplasia
Edwards et al. (2003) [32] 1997-1998 UK Morbidity: lymphoma
Bonnett et al. (2005) [33] 1995-2000 Sweden Mortality; general, by cause
Davison et al. (2005) [57] Not stated UK Diabetes mellitus3
Egenvall et al. (2005) [58] 1995-2000 Sweden Mortality; general, by cause
Egenvall et al. (2005) [34] 1995-2002 Sweden Morbidity and mortality; mammary tumours
Bergström et al. (2006) [47] 1995-2002 Sweden Morbidity; Caesarean section
Egenvall et al. (2006) [59] 1995-2002 Sweden Mortality; heart disease
Nødtvedt et al. (2006) [60] 1995-2002 Sweden Morbidity; atopic dermatitis
Nødtvedt et al. (2007) [43] 1995-2002 Sweden Morbidity; atopic dermatitis, spatial distribution
Egenvall et al. (2007) [35] 1995-2002 Sweden Morbidity and mortality; osteosarcoma
Fall et al. (2007) [61] 1995-2004 Sweden Morbidity and mortality; diabetes mellitus
1 Data from Swedish studies (n = 16) emanates from Agria insurance http://www.agria.se and data from UK (n = 3) from PetProtect http://
www.petprotect.co.uk
2 All included studies have included incidence measures
3 morbidity/mortality not stated
Table 2: Published studies (n = 13) based on data from insured horses in chronological order
Source Year Country1 Main focus/disease
Greenhall et al. (1979) [19] 1978-1979 US2 Mortality; by cause3
Bergsten et al. (1983) [62] 1973-1981 Sweden Mortality; locomotor problem
Clausen et al. (1990) [29] 1977-1987 Germany4 Morbidity; general. by cause2
Hommerich et al. (1995) [20] 1984-1994 Germany5 Mortality; by cause
LeBlond et al. (2000) [28] 1995 France6 Mortality; general, by cause
Egenvall et al. (2005) [25] 1997-2000 Sweden Morbidity; general
Penell et al. (2005) [26] 1997-2000 Sweden Morbidity; by cause
Egenvall et al. (2006a) [27] 1997-2000 Sweden Mortality; general, by cause
Egenvall et al. (2006b) [63] 1997-2002 Sweden Mortality; general, locomotor problems
Higuchi (2006) [51] 2001-2003 Japan Morbidity and mortality; colic
Egenvall et al. (2008) [39] 1997-2002 Sweden Morbidity; general, locomotor problems
Egenvall et al. (2008) [40] 1997-2002 Sweden Morbidity and mortality; colic
Egenvall et al. (2009) [41] 1997-2002 Sweden Morbidity and mortality; riding schools horses, locomotor problems
1 Data from Swedish studies (n = 8) emanates from Agria insurance http://www.agria.se and various companies provided data for the other studies
2 Rhulen Agency, Inc, Monticello NY
3 only proportional measures presented
4 not stated
5 Vereinigten Tierversicherung Gesellschaft a.G.
6 data from 9 of 42 identified French horse insurance companies.Page 4 of 9
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both for morbidity and mortality in insured horses
[20,26,27,29].
From the Agria insurance database, the most common
specific causes of death in dogs are tumour, trauma, loco-
motor and heart problems [22]. In dogs, the most com-
mon causes of morbidity were skin, digestive, genital and
respiratory tract problems [24]. In horses, the most com-
mon reasons for mortality were; joint, skeletal, hoof and
digestive disorders and for veterinary care events; joint,
skin, digestive and skeletal disorders [26,27]. However,
behavioral problems have been shown to be a common
cause of canine euthanasia in Denmark [30]. Because such
problems are generally not covered by the Agria insur-
ance, any discrepancy between total and diagnostic mor-
tality may be (at least partially) accounted for by
unclaimed behavior problems. This may vary across
breeds. For example, for mixed breed dogs the proportion
of all deaths that were claimed was around 50%. In some
breeds, e.g. Bernese Mountain Dogs and Cavalier King
Charles Spaniels, over 80% of deaths have an associated
diagnosis and behavior problems are unlikely to account
for many deaths. Other reasons may influence the lack of
claims, however, including owner reluctance to receive
money following the death of their pet or simple over-
sight.
Even though there are among-study similarities, it is
expected that comparisons between breeds or across ages
are best done within each study. This is because of under-
lying differences in, e.g. insurance policies, analytical
methods or time effects.
Neoplasia
Dobson and co-workers [31] published rates of canine
neoplasia based on data from an insurance company in
the UK, where case records were scrutinised for classifica-
tion of tumour type. The rates were age-standardised to an
estimated composition of the UK dog population. Statis-
tics on lymphoma in dogs were published from the same
material [32]. From the Swedish insurance database [33-
35], rates have been constructed for the incidence of
mammary tumours (age-standardised from UK 205 per
dogs per 100,000 dogs/year and crude from Sweden 1110
dogs per 100,000 dog-years at risk) and osteosarcoma
(from UK: 57 per dogs per 100 000 dogs/year (age-stand-
ardised); from Sweden 55 dogs per 100,000 dog-years at
risk), as well as for the overall neoplasia rate (from UK
crude and standardised 1948 and 2671 cases per 100 000
dogs/year and crude mortality from Sweden 500 deaths
per 100,000 dog-years at risk) the latter reflected solely
from life-insurance claims. Crude and age-standardised
rates of lymphosarcoma of 79 and 107 cases per 100 000
dogs/year, respectively, was estimated for dogs in the UK,
and from Sweden a crude mortality (life-insurance
claims) of 90 deaths per 100,000 dog-years at risk [31-33].
In conclusion, the rates of osteosarcoma and lymphosar-
coma are similar between the two countries, while dis-
crepancies are larger for the other diseases. The likely
reason for this similarity may be that the former diseases
are highly malignant and therefore most owners will seek
medical care and the disease occurrence will be registered
if the dog has insurance (the owner will seek medical
advice because the dog has moderate to severe clinical
signs and the condition likely becomes diagnosed because
it is relatively simple to determine the diagnosis). When
the conditions are less malignant, insurance-, owner- and
dog-related factors, as well as prognostic and cost consid-
erations about pursuit of, e.g. diagnostic work-up or ther-
apy, may all influence access to veterinary care and
subsequent entry of information to the database.
Survival estimates
Survival estimates for dogs up to 10 years of age and
horses up 22 years of age have been presented based on
Swedish animal insurance data [27,36]. These rates agree
well with those from primary data collection [37], and
with survival estimates from horses entering quality con-
tests [17]. However, estimated canine survival from the
VMDP database [8] agreed poorly with the results from
Sweden, which we believe mainly is caused by the fact that
the VMDP database solely contains cases. The conclusion
is that estimates of length of life should be possible to
derive from life-insurance databases with good coverage.
Because life-insurance coverage is likely to terminate at a
certain age, these calculations will only be possible to that
age. Furthermore, all insured animals will have already
survived to the age at which they were insured and esti-
mates from insurance data disregard deaths occurring at
very young age.
Frame for gathering study populations, adding extra data 
from interviews or practice records
In England, an insurance database was used as a sampling
frame for interviews about causes of canine death [38].
The possibility for identifying cases and high risk groups
from insurance databases can support various research
designs, with due consideration of confidentiality issues
(see below).
Costs of veterinary care
It is inherent in insurance veterinary care data that veteri-
nary care costs are attached to each receipt. A few times it
has been possible to demonstrate the gross cost of general
or specific veterinary care [39-42]. For example, a substan-
tial increase in costs for general veterinary care in horses
was found over an 8-year time period using Swedish data.
Between the years 1997 and 2004, the increase in costs per
claimed horse was 59% and the increase in cost per horse-
year at risk was 41%, compared to a consumer's price
index increase of only 10% [42]. Veterinary costs are anPage 5 of 9
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mal interactions and, in spite of limitations relative to the
nature of insurance reimbursements the information is
useful. Findings from longitudinal studies of subsequent
risk following initial diagnosis of disease problems from
insurance data could ideally be combined with clinical
outcome evaluations in an effort to determine effective
management strategies and to support diagnostic decision
making.
Benefits of and limitations for using animal 
insurance data in research
Benefits of using animal insurance data in research
Obvious benefits of insurance databases are that they
already exist and contain information that can be
accessed. Given that an insurance company gives permis-
sion to access data, they become relatively straightforward
to manage, even if many computational problems may
arise during the process. Still, there is less work and lower
cost compared to assembling a similar amount of infor-
mation through primary data collection. Primary data col-
lection, of course, is not free of limitations, e.g.
representativeness of the sample for the target population,
volunteer bias and non-response issues.
Many insurance databases are large and high statistical
power can be achieved. They are therefore relatively well
suited to analyse for example breed effects. Dog breeds
differ widely in size and conformation as well as regarding
disease patterns. Unfortunately, in most observational
studies interactions between dog breeds and other factors
are rarely explored simply because there are often few
dogs of many different breeds.
An insurance database contains detailed information
about the addresses of the owners. Because of billing and
communication reasons the locations of the owners are
regularly updated. Our group studied the impact of geo-
graphic factors (e.g. distribution of specialised veterinari-
ans) on the occurrence of atopic dermatitis among dogs
insured by Agria using spatial analysis [43]. However, it
may be more difficult or impossible to follow the move-
ment of persons and animals over time and the assump-
tion that the animal resides solely at the location of the
owner's primary address may not always be valid and is
likely less accurate for horses than dogs.
Our experience is that data can be handled so as to main-
tain confidentiality of client and animal information. It is
generally not an objective to describe individual animals,
therefore confidentiality can be maintained. However, the
ethical and legal considerations of the data usage must
always be considered, especially if there is any linkage to
other databases or information that could be used to iden-
tify individuals.
Limitations of using animal insurance data in research
Validity of the data
Once compiled, a "research insurance database" is techni-
cally easy to analyse for a number of disease problems.
However, different problems may require various strate-
gies and precautions. Most of the Swedish publications
have analysed problems at a rather crude level of diagnos-
tic detail, where the authors have been satisfied with the
data validity. The major challenge for more specific diag-
noses is to correctly identify (all) the cases of interest. This
is influenced not only by the data, but by e.g. the acumen
of the veterinarians supplying the data and even the gen-
eral culture of access to care relative to specific conditions.
Factors specific to each disease/problem proposed for
study must be considered, optimal strategies employed,
or, in the case of, e.g. unavailable or inaccurate data, the
study of that condition abandoned. Some "simple" diag-
noses might have one easily identifiable code, be correctly
coded to a large extent (have a high positive predictive
value) and be found in the database when present (have a
high observed sensitivity). However, for many complex
disease problems these conditions may not be satisfied.
Review of original practice records, validation of specific
diagnoses or other more intensive strategies may be
needed to supplement the insurance data.
In the Swedish insurance database used in research, all
veterinarians provide diagnoses using a standardized
diagnostic registry [44]. This provides a level of consist-
ency but the underlying accuracy is unknown. Veterinari-
ans often use non-specific codes (e.g. 'dead, no diagnosis,
or 'clinical sign of illness'). This may reflect the realities of
veterinary practice, but is, of course, a limitation to
detailed investigation. Often, only one diagnostic code is
allowed for each receipt. Validation has shown this to
result in high correctness, i.e. the animal did experience
that event [45,46]. However, such a system also reduces
completeness, as not all the problems an animal experi-
ences will be recorded.
For some conditions, e.g. Caesarean section in bitches
[47] coding is likely very accurate. However, because of
insurance company restrictions, it was only possible to
study the first event of Caesarean section. As another
example of a specific condition, a sample of records from
dogs with the diagnosis atopic dermatitis was investigated
[48]. Of the scrutinized cases, all were recorded by the
submitting veterinarian to be suffering from canine atopic
dermatitis and 98% were judged by the principal investi-
gator as having allergic skin disease. However, for a large
number of dogs cutaneous adverse food reactions had not
been properly ruled out and in total it was suggested that
approximately 75% of the cases had canine atopic derma-
titis or canine atopic dermatitis with concurrent cutane-
ous adverse food reactions.Page 6 of 9
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bases is challenging and generally not followed to an ade-
quate extent in those limited sources reported for
companion animals. The Agria insurance database was
initially validated for dogs and for horses [45,46] showing
that diagnostic agreement approached 85%, while for
demographic variables it was > 94% [45,46]. However,
monitoring the health situation over time can be a chal-
lenge if insurance terms (e.g. premiums, relative deducti-
bles and maximal reimbursements) change significantly.
External validity (Representativeness of the population)
The extent to which findings from an insured population
can be extrapolated to other populations is difficult to
assess. The proportion of a population in a country that is
insured by a given insurance company should be
accounted for. For example in Sweden, around a third of
all horses have complete insurance by Agria (excluding all
racing horses) and the same share of the dog population
is estimated to be covered by the same company (a major-
ity of all dogs are insured). Insurance coverage has been
shown to vary somewhat by breed [49] and if insurance
coverage ends at a certain age, old dogs will not be covered
and statistics will not be relevant for these. It has also been
determined that this insured population was reasonably
representative of the general Swedish dog population with
regard to feeding and exercise [50].
Findings for morbidity and mortality for insured animals
cannot be presumed to apply to the uninsured popula-
tion. Veterinary care may be accessed less by owners of
non-insured compared to insured animals. Uninsured
animals may also have fewer medical procedures per-
formed. Even mortality, based on decisions to euthanize
animals, may be different depending on insurance status.
Also insurance enrolment may vary related to the use/
function of the animal. If so, the extent of disease and
injury, if associated with usage, may vary from the insured
to the non-insured population. This is likely true, but, for
the Swedish population, it may not be as significant as
one might suppose, even for the horse population, as
both high-level competition (non-racing) horses and
backyard horses are insured to a large extent (personal
observations). However, the likelihood of the owner
accessing veterinary care seems to vary even within the
insured population, perhaps influenced by personal, geo-
graphical and economic factors (unpublished informa-
tion).
Benefits of and limitations for comparison across studies
Notwithstanding all the limitations which must be duly
considered, it is possible and useful to compare appropri-
ately compiled research findings within the insured pop-
ulation of an individual company, across companies,
within a country or across countries. In Sweden, we
believe that we can extrapolate to the total insured-dog
population in this country. In addition, for many specific
breeds we believe the findings are informative outside of
Sweden. Many dog breeds in Sweden have close genetic
links to breeding lines in UK and other European coun-
tries. Where diseases may be a function of, for example,
size or function, extrapolation to similar dogs in other
countries is reasonable. For horses there is a limitation
that actively competing/training trotters and thorough-
breds have "less" coverage, mainly because the insurance
forms for such horses do not cover all types of medical
problems. With this exception, findings from the Agria
horse population are likely informative both within and
outside of Sweden. Extrapolation should be done cau-
tiously, with due consideration of possible similarities to
or differences from the Swedish populations and situa-
tion. However, studies on the same disease complexes
from different countries are welcomed for comparison.
Smaller differences in results between national popula-
tions might very well be due to different strategies of
insuring animals (for example the ease and degrees that
people can switch company, or reinsure an animal that
has quit insurance, or policies of continued coverage
when owners have used the insurance for expensive veter-
inary care).
It can be seen from the above that several issues can com-
plicate between-study comparisons, best exemplified
from the neoplasia section. Even if the same disease is
studied, different incidences may be estimated if studying
all claims (i.e. veterinary care) compared to only life-
insurance claims (deaths). We believe one of the major
reasons for the observed differences when comparing
results between insurance databases or between different
sources is the possibility for inclusions of different type of
cases. For example, colic cases from an insurance database
are likely in general more severe [40,51] compared to
those from a primary study with data from animal holders
[5,52], even though cases will be less severe than in a
study on surgical colic from a hospital database [53]. (I.e.
the cases in the insured population will not be found in
the database until they have reached the deductible, ani-
mal holders will register all colics including self-limiting
problems and surgical colic cases are by definition not eli-
gible until costly surgery has taken place.) Many issues
that complicate comparison across studies are not unique
to insurance data, and must always be kept in mind when
extrapolating information from the literature.
Judging by the number of publications, it is clear that the
Swedish insurance company Agria has been extremely
open about sharing their data with the scientific commu-
nity, perhaps more so than other companies world-wide.
This has allowed for a thorough description of at least this
insured population. For example, censoring (withdrawal)
rates have been reported from many of the Swedish stud-Page 7 of 9
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dom been demonstrated. Comparing Swedish horses and
dogs, the censoring rates of the horses are much higher. As
horses are sold and bought to a much larger extent this
feature is expected, but we believe it is an advantage to be
able to document it as well.
Conclusion and future use of insurance 
databases
Our research-group intends to continue analysis of Swed-
ish animal insurance statistics for dogs and horses and to
also include cats in the future. Perhaps use of animal
insurance data from Sweden and the UK will expand and
companies in other countries will allow researchers to
access their data. However, detailed information on the
insurance policies, populations and data must be availa-
ble to address the concerns and limitations described
above. The basic tenet of animals being 'at risk' must be
satisfied. In other words, there must be realistic assurance
that if an insured animal experienced an event of interest,
it would be recorded within the database. It is quite likely
that given changes in the economy, in general, and with
increasing costs of veterinary care, there may be changes in
the animal insurance industry. Increased restrictions, lim-
itations on coverage and increased individualization of
policies may impact the usefulness of insurance data for
research.
A possible extension of research based on insurance data
is the construction and dissemination of detailed statistics
not only back to the insurance companies but especially
to breed clubs, breeders and owners. The latter has
recently been launched using data from Agria, where sta-
tistics have been compiled and distributed to Swedish
breed clubs (for breeds with a reasonably large base pop-
ulation) [54]. Recent focus on diseases in purebred dogs
underscores the importance of getting health information
into the hands of the end-users, i.e. dog breeders, in a
user-friendly format with pertinent content.
We conclude that insurance data can and should be used
for research purposes in companion animals and horses.
They are simply too useful of a resource to ignore as they
can fill certain gaps left by other types of research. Insur-
ance data have been successfully used, e.g. to quantify cer-
tain features that may have been hitherto assumed, but
unmeasured. Validation of insurance databases is neces-
sary if they are to be used in research. This must include
the description of the insured population and an evalua-
tion of the extent to which it represents the source popu-
lation. Data content and accuracy must be determined
over time, including the accuracy/consistency of diagnos-
tic information. Readers must be cautioned as to limita-
tions of the databases and, as always, critically appraise
findings and synthesize information with other research.
Similar findings from different study designs provide
stronger evidence than a sole report. Insurance data can
highlight common, expensive and severe conditions that
may not be evident from teaching hospital case loads but
may be significant burdens on the health of a population.
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